A new system for fast and affordable DNA sequencing
Official title: High-Throughput DNA Sequencing System
Funded at Dana-Farber Cancer Inst · NIH-10851325 · Data updated 2026-11-12
This study is about getting a new high-tech machine that will help scientists at Dana-Farber Cancer Institute quickly and affordably look at genes and understand how they work, which could lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 15, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,035,125 |
| NIH project number | 1S10OD036228-01 |
| Project ID | NIH-10851325 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals requiring detailed genomic analysis for cancer or other genetic conditions.
✕Less likely to help
Patients who do not require genomic testing or those with conditions not related to genetic factors may not receive benefit from this research.
What this research studies
This research focuses on acquiring a NovaSeq X Plus system to enhance the capabilities of the Molecular Biology Core Facilities at the Dana-Farber Cancer Institute. The new system will enable rapid and cost-effective whole genome sequencing, methylation profiling, and single-cell genomics. By improving access to advanced genomic technologies, this project aims to support a wide range of molecular biology applications, making it easier for researchers to conduct large-scale studies. Patients may benefit from the enhanced understanding of their genetic information through improved research outcomes.
Why it matters
Potential benefit: If successful, this research could provide patients with faster and more affordable access to comprehensive genomic testing.
How similar studies have gone: Previous research has shown success with similar high-throughput sequencing technologies, indicating a strong potential for impactful outcomes.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Herbert, Zachary T — Dana-Farber Cancer Inst
- Study coordinator: Herbert, Zachary T
Related research
Other NIH-funded projects on the same topics.
-
Helping young people with cancer understand their genetic risks
This study is creating a special program to help teenagers and young adults with hereditary cancer risks learn about their health and make smart choices, while also supporting their families along the way.
-
Core administrative hub for a multifaceted cancer center program
A large, international cancer research program at Dana-Farber aims to advance a curative strategy for multiple myeloma by coordinating translational research, clinical trials, and data analysis.
-
Automated, interactive lab tool to define radiation targets in cancer care
Aims to make it easier and safer to outline the area to treat in radiation therapy for cancers by using smart software and a patient-friendly interface.
-
Cancer Atlas Network data hub to share big cancer data
A national project helps researchers store, harmonize, and share large cancer data collections so doctors and scientists can learn from many patients.
-
Bridge-building cancer research partnership for education, outreach, and science
A joint effort between UMass Boston and Harvard Cancer Consortium to accelerate cancer research and education by connecting lower-resourced institutions with a leading cancer center.
-
NexTGen: Next-Generation T cell therapy for childhood cancers
A charity-friendly overview: researchers at Dana-Farber are developing advanced engineered T-cell therapies to treat pediatric solid cancers like brain tumors and sarcomas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.